NCT04649060 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 54
- units
- Participants
- groups
- description
- Treatment was given in 28-day cycles in an outpatient treatment setting. * Melflufen 30 mg intravenous (i.v.) infusion on Day 1 of each cycle * Dexamethasone 40 mg per oral (p.o.) weekly (20 mg p.o. weekly if ≥75 years) * Daratumumab 1800 mg subcutaneously (s.c.) on Days 1, 8, 15, and 22 in Cycles 1 and 2, on Days 1 and 15 in Cycles 3 to 6, and on Day 1 from Cycle 7
- id
- BG000
- title
- Arm A (Melflufen+Dexamethasone+Daratumumab)
- description
- Treatment was given in 28-day cycles in an outpatient treatment setting. • Daratumumab 1800 mg s.c. on Days 1, 8, 15, and 22 in Cycles 1 and 2, on Days 1 and 15 in Cycles 3 to 6, and on Day 1 from Cycle 7
- id
- BG001
- title
- Arm B (Daratumumab)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 43
- upper Limit
- 80
- value
- 64.5
- group Id
- BG001
- lower Limit
- 50
- upper Limit
- 83
- value
- 66.7
- group Id
- BG002
- lower Limit
- 43
- upper Limit
- 83
- value
- 65.6
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 20
- title
- <65
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 29
- title
- 65 - ≤75
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- >75
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 21
- title
- Female
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 33
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 54
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 54
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 61.0
- upper Limit
- 103.8
- value
- 79.46
- group Id
- BG001
- lower Limit
- 56.3
- upper Limit
- 107.6
- value
- 78.75
- group Id
- BG002
- lower Limit
- 56.3
- upper Limit
- 107.6
- value
- 79.1
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 151
- upper Limit
- 195
- value
- 170.4
- group Id
- BG001
- lower Limit
- 150
- upper Limit
- 188
- value
- 167.0
- group Id
- BG002
- lower Limit
- 150
- upper Limit
- 195
- value
- 168.7
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- title
- score = 0
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 33
- title
- score = 1
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 7
- title
- score = 2
- description
- 0=Normal activity, fully active, able to carry on all pre-disease performance without restriction. 1=Symptoms, but fully ambulatory, restricted in physically strenuous but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group (ECOG) score
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 54
- units
- Participants
- groups
- description
- Treatment was given in 28-day cycles in an outpatient treatment setting. * Melflufen 30 mg intravenous (i.v.) infusion on Day 1 of each cycle * Dexamethasone 40 mg per oral (p.o.) weekly (20 mg p.o. weekly if ≥75 years) * Daratumumab 1800 mg subcutaneously (s.c.) on Days 1, 8, 15, and 22 in Cycles 1 and 2, on Days 1 and 15 in Cycles 3 to 6, and on Day 1 from Cycle 7
- id
- BG000
- title
- Arm A (Melflufen+Dexamethasone+Daratumumab)
- description
- Treatment was given in 28-day cycles in an outpatient treatment setting. • Daratumumab 1800 mg s.c. on Days 1, 8, 15, and 22 in Cycles 1 and 2, on Days 1 and 15 in Cycles 3 to 6, and on Day 1 from Cycle 7
- id
- BG001
- title
- Arm B (Daratumumab)
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 43
- upper Limit
- 80
- value
- 64.5
- group Id
- BG001
- lower Limit
- 50
- upper Limit
- 83
- value
- 66.7
- group Id
- BG002
- lower Limit
- 43
- upper Limit
- 83
- value
- 65.6
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 20
- title
- <65
- categories
- measurements
- group Id
- BG000
- value
- 13
- group Id
- BG001
- value
- 16
- group Id
- BG002
- value
- 29
- title
- 65 - ≤75
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 5
- title
- >75
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 11
- group Id
- BG001
- value
- 10
- group Id
- BG002
- value
- 21
- title
- Female
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 17
- group Id
- BG002
- value
- 33
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 54
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 54
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 61.0
- upper Limit
- 103.8
- value
- 79.46
- group Id
- BG001
- lower Limit
- 56.3
- upper Limit
- 107.6
- value
- 78.75
- group Id
- BG002
- lower Limit
- 56.3
- upper Limit
- 107.6
- value
- 79.1
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Weight
- unit Of Measure
- kg
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 151
- upper Limit
- 195
- value
- 170.4
- group Id
- BG001
- lower Limit
- 150
- upper Limit
- 188
- value
- 167.0
- group Id
- BG002
- lower Limit
- 150
- upper Limit
- 195
- value
- 168.7
- dispersion Type
- FULL_RANGE
- param Type
- MEAN
- title
- Height
- unit Of Measure
- cm
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 14
- title
- score = 0
- measurements
- group Id
- BG000
- value
- 18
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 33
- title
- score = 1
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 6
- group Id
- BG002
- value
- 7
- title
- score = 2
- description
- 0=Normal activity, fully active, able to carry on all pre-disease performance without restriction. 1=Symptoms, but fully ambulatory, restricted in physically strenuous but ambulatory and able to carry out work of a light or sedentary nature (e.g., light housework, office work). 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Eastern Cooperative Oncology Group (ECOG) score
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle